-
201
Mechanism of melanoma suppression by Prosopis juliflora derived alkaloids: Apoptosis induction and signaling pathway inhibition
Published 2025-02-01“…Our prior studies highlighted the anti-melanoma potential of Prosopis juliflora leave methanolic extract (PJLME), leading us to further isolate and characterize bioactive compounds from PJLME and evaluate their efficacy against melanoma. …”
Get full text
Article -
202
Retracted: Long Noncoding RNA SAMMSON Promotes Melanoma Progression by Inhibiting FOXA2 Expression
Published 2024-01-01Get full text
Article -
203
A Case Report of Melanoma as Acute Mastoiditis in a 10-Month-Old Female Child
Published 2019-01-01“…We present a rare case of transplacental-transmitted maternal melanoma to the placenta and foetus during the pregnancy of a 34-year-old woman. …”
Get full text
Article -
204
Pharmacokinetic Evaluation of [C]CEP-32496 in Nude Mice Bearing BRAF Mutation-Induced Melanomas
Published 2018-09-01“…These were followed by PET scans and biodistribution studies on nude mice bearing subcutaneous A375 cell-induced melanoma. [ 11 C]CEP-32496 showed high binding affinity for BRAF V600E -positive A375 melanoma cells and densely accumulated in the respective tissue sections; this could be blocked by the BRAF V600E selective antagonist sorafenib and by unlabeled CEP-32496. …”
Get full text
Article -
205
Inguinal Lymph Node Dissection for Advanced Stages of Plantar Melanoma in a Low-Income Country
Published 2020-01-01“…Advanced stages of plantar acral lentiginous melanoma are common in Africa. Inguinal lymph node dissection (ILND) in these cases plays a critical role in disease-free and overall survival. …”
Get full text
Article -
206
Causal Association Between Skin Microbiota and Malignant Melanoma: Genetic Insights From Mendelian Randomization
Published 2025-01-01Subjects: Get full text
Article -
207
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Published 2023-01-01“…Background Accumulating data suggest that mucosal melanoma, well known for its poor response to immune checkpoint blockade (ICB) and abysmal prognosis, is a heterogeneous subtype of melanoma with distinct genomic and clinical characteristics between different anatomic locations of the primary lesions. …”
Get full text
Article -
208
Trace elements selenium and potassium are protective factors for cutaneous malignant melanoma: A Mendelian randomization study
Published 2025-02-01Subjects: Get full text
Article -
209
-
210
Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2
Published 2010-01-01“…Nuclear hormone receptors, including RXR and PPARγ, represent novel therapeutic targets in melanoma. We have previously shown that the DRO subline of the amelanotic melanoma A375 responds to rexinoid and thiazolidinedione (TZD) treatment in vitro and in vivo. …”
Get full text
Article -
211
Defining the high-risk category of patients with cutaneous melanoma: a practical tool based on prognostic modeling
Published 2025-02-01Subjects: “…cutaneous melanoma…”
Get full text
Article -
212
Late Metastatic Melanoma after 25 Years: A Case Report and a Brief Literature Review
Published 2020-01-01“…The incidence of cutaneous malignant melanoma has shown a drastic increase over recent decades, and approximately 70% of newly diagnosed melanoma are tumors with a Breslow thickness less or equal to 1 mm. …”
Get full text
Article -
213
A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma
Published 2013-01-01“…A number of trials of adoptive transfer of tumor-specific T lymphocytes have been performed in the last 20 years in metastatic melanoma, with increasingly encouraging results as the relevant melanoma antigens were identified and the purity/specificity of injected T cells improved. …”
Get full text
Article -
214
Development of a prognostic nomogram for ocular melanoma: a SEER population-based study (2000–2021)
Published 2025-01-01Subjects: “…ocular melanoma…”
Get full text
Article -
215
Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations
Published 2025-01-01Subjects: “…Melanoma…”
Get full text
Article -
216
Transcriptome analysis of novel B16 melanoma metastatic variants generated by serial intracarotid artery injection
Published 2025-01-01Subjects: “…Melanoma…”
Get full text
Article -
217
Halo Nevi Are Not Trivial: About 2 Young Patients of Regressed Primary Melanoma That Simulates Halo Nevi
Published 2021-01-01“…We present two case reports suggesting that a halo nevus appearance can be seen in melanoma, even in young adults. A literature search for halo nevi revealing melanoma shows that this is a very rare condition. …”
Get full text
Article -
218
Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis
Published 2025-01-01“…Here, we investigated the pathogenic mechanisms driving melanoma-induced osteocyte death. Both in vivo models and in vitro assays were combined with untargeted RNA sequencing approaches to explore the pathways governing melanoma-induced osteocyte death. …”
Get full text
Article -
219
Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
Published 2015-01-01“…Malignant melanoma is a devastating disease whose incidences are continuously rising. …”
Get full text
Article -
220
Co-Delivery of Dacarbazine and miRNA 34a Combinations to Synergistically Improve Malignant Melanoma Treatments
Published 2025-01-01Subjects: Get full text
Article